CME Group Inc. (NASDAQ:CME – Get Free Report) has earned a consensus recommendation of “Reduce” from the fifteen ratings firms that are presently covering the stock, Marketbeat.com reports. Four investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating on the company. The average 1 year price target among analysts that have issued ratings on the stock in the last year is $229.27.
A number of analysts have recently issued reports on the company. Piper Sandler raised their price objective on CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research report on Tuesday, January 7th. Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CME Group from $227.00 to $226.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Morgan Stanley raised their target price on shares of CME Group from $210.00 to $233.00 and gave the stock an “equal weight” rating in a research note on Thursday, October 17th. Royal Bank of Canada reiterated a “sector perform” rating and issued a $235.00 price target on shares of CME Group in a research note on Monday, January 6th. Finally, Keefe, Bruyette & Woods cut their price objective on shares of CME Group from $260.00 to $256.00 and set a “market perform” rating for the company in a research report on Monday, January 13th.
Get Our Latest Research Report on CME Group
Institutional Inflows and Outflows
CME Group Stock Down 1.2 %
CME Group stock opened at $241.81 on Friday. CME Group has a fifty-two week low of $190.70 and a fifty-two week high of $249.02. The firm has a market capitalization of $87.14 billion, a PE ratio of 25.43, a P/E/G ratio of 5.54 and a beta of 0.57. The company’s 50-day moving average is $235.48 and its 200-day moving average is $224.32. The company has a debt-to-equity ratio of 0.09, a current ratio of 1.02 and a quick ratio of 1.02.
CME Group announced that its Board of Directors has authorized a share buyback plan on Thursday, December 5th that allows the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization allows the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares repurchase plans are generally an indication that the company’s board believes its stock is undervalued.
CME Group Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Shareholders of record on Friday, March 7th will be paid a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 2.07%. This is an increase from CME Group’s previous quarterly dividend of $1.15. The ex-dividend date of this dividend is Friday, March 7th. CME Group’s dividend payout ratio is presently 52.58%.
CME Group Company Profile
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- What is the Euro STOXX 50 Index?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- ESG Stocks, What Investors Should Know
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Investing In Automotive Stocks
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.